Negatively charged silver nanoparticles with potent antibacterial activity and reduced toxicity for pharmaceutical preparations

Lucia Salvioni, Elisabetta Galbiati, Veronica Collico, Giulia Alessio, Svetlana Avvakumova, Fabio Corsi, Paolo Tortora, Davide Prosperi, Miriam Colombo

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Background: The discovery of new solutions with antibacterial activity as efficient and safe alternatives to common preservatives (such as parabens) and to combat emerging infections and drug-resistant bacterial pathogens is highly expected in cosmetics and pharmaceutics. Colloidal silver nanoparticles (NPs) are attracting interest as novel effective antimicrobial agents for the prevention of several infectious diseases. Methods: Water-soluble, negatively charged silver nanoparticles (AgNPs) were synthesized by reduction with citric and tannic acid and characterized by transmission electron microscopy, dynamic light scattering, zeta potential, differential centrifuge sedimentation, and ultraviolet–visible spectroscopy. AgNPs were tested with model Gram-negative and Gram-positive bacteria in comparison to two different kinds of commercially available AgNPs. Results: In this work, AgNPs with higher antibacterial activity compared to the commercially available colloidal silver solutions were prepared and investigated. Bacteria were plated and the antibacterial activity was tested at the same concentration of silver ions in all samples. The AgNPs did not show any significant reduction in the antibacterial activity for an acceptable time period. In addition, AgNPs were transferred to organic phase and retained their antibacterial efficacy in both aqueous and nonaqueous media and exhibited no toxicity in eukaryotic cells. Conclusion: We developed AgNPs with a 20 nm diameter and negative zeta potential with powerful antibacterial activity and low toxicity compared to currently available colloidal silver, suitable for cosmetic preservatives and pharmaceutical preparations administrable to humans and/or animals as needed.

Original languageEnglish
Pages (from-to)2517-2530
Number of pages14
JournalInternational Journal of Nanomedicine
Volume12
DOIs
Publication statusPublished - Mar 31 2017

Fingerprint

Silver
Nanoparticles
Drug products
Toxicity
Cosmetics
Zeta potential
Bacteria
Parabens
Pharmaceutical Preparations
Tannins
Centrifuges
Gram-Positive Bacteria
Eukaryotic Cells
Pathogens
Dynamic light scattering
Anti-Infective Agents
Transmission Electron Microscopy
Sedimentation
Citric Acid
Communicable Diseases

Keywords

  • Antibacterial activity
  • Long-term effect
  • Nanoparticle toxicity
  • Phase transfer
  • Silver nanoparticles

ASJC Scopus subject areas

  • Bioengineering
  • Biophysics
  • Biomaterials
  • Drug Discovery
  • Organic Chemistry

Cite this

Negatively charged silver nanoparticles with potent antibacterial activity and reduced toxicity for pharmaceutical preparations. / Salvioni, Lucia; Galbiati, Elisabetta; Collico, Veronica; Alessio, Giulia; Avvakumova, Svetlana; Corsi, Fabio; Tortora, Paolo; Prosperi, Davide; Colombo, Miriam.

In: International Journal of Nanomedicine, Vol. 12, 31.03.2017, p. 2517-2530.

Research output: Contribution to journalArticle

Salvioni, Lucia ; Galbiati, Elisabetta ; Collico, Veronica ; Alessio, Giulia ; Avvakumova, Svetlana ; Corsi, Fabio ; Tortora, Paolo ; Prosperi, Davide ; Colombo, Miriam. / Negatively charged silver nanoparticles with potent antibacterial activity and reduced toxicity for pharmaceutical preparations. In: International Journal of Nanomedicine. 2017 ; Vol. 12. pp. 2517-2530.
@article{374410be156549d08c838af2ea115769,
title = "Negatively charged silver nanoparticles with potent antibacterial activity and reduced toxicity for pharmaceutical preparations",
abstract = "Background: The discovery of new solutions with antibacterial activity as efficient and safe alternatives to common preservatives (such as parabens) and to combat emerging infections and drug-resistant bacterial pathogens is highly expected in cosmetics and pharmaceutics. Colloidal silver nanoparticles (NPs) are attracting interest as novel effective antimicrobial agents for the prevention of several infectious diseases. Methods: Water-soluble, negatively charged silver nanoparticles (AgNPs) were synthesized by reduction with citric and tannic acid and characterized by transmission electron microscopy, dynamic light scattering, zeta potential, differential centrifuge sedimentation, and ultraviolet–visible spectroscopy. AgNPs were tested with model Gram-negative and Gram-positive bacteria in comparison to two different kinds of commercially available AgNPs. Results: In this work, AgNPs with higher antibacterial activity compared to the commercially available colloidal silver solutions were prepared and investigated. Bacteria were plated and the antibacterial activity was tested at the same concentration of silver ions in all samples. The AgNPs did not show any significant reduction in the antibacterial activity for an acceptable time period. In addition, AgNPs were transferred to organic phase and retained their antibacterial efficacy in both aqueous and nonaqueous media and exhibited no toxicity in eukaryotic cells. Conclusion: We developed AgNPs with a 20 nm diameter and negative zeta potential with powerful antibacterial activity and low toxicity compared to currently available colloidal silver, suitable for cosmetic preservatives and pharmaceutical preparations administrable to humans and/or animals as needed.",
keywords = "Antibacterial activity, Long-term effect, Nanoparticle toxicity, Phase transfer, Silver nanoparticles",
author = "Lucia Salvioni and Elisabetta Galbiati and Veronica Collico and Giulia Alessio and Svetlana Avvakumova and Fabio Corsi and Paolo Tortora and Davide Prosperi and Miriam Colombo",
year = "2017",
month = "3",
day = "31",
doi = "10.2147/IJN.S127799",
language = "English",
volume = "12",
pages = "2517--2530",
journal = "International Journal of Nanomedicine",
issn = "1176-9114",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Negatively charged silver nanoparticles with potent antibacterial activity and reduced toxicity for pharmaceutical preparations

AU - Salvioni, Lucia

AU - Galbiati, Elisabetta

AU - Collico, Veronica

AU - Alessio, Giulia

AU - Avvakumova, Svetlana

AU - Corsi, Fabio

AU - Tortora, Paolo

AU - Prosperi, Davide

AU - Colombo, Miriam

PY - 2017/3/31

Y1 - 2017/3/31

N2 - Background: The discovery of new solutions with antibacterial activity as efficient and safe alternatives to common preservatives (such as parabens) and to combat emerging infections and drug-resistant bacterial pathogens is highly expected in cosmetics and pharmaceutics. Colloidal silver nanoparticles (NPs) are attracting interest as novel effective antimicrobial agents for the prevention of several infectious diseases. Methods: Water-soluble, negatively charged silver nanoparticles (AgNPs) were synthesized by reduction with citric and tannic acid and characterized by transmission electron microscopy, dynamic light scattering, zeta potential, differential centrifuge sedimentation, and ultraviolet–visible spectroscopy. AgNPs were tested with model Gram-negative and Gram-positive bacteria in comparison to two different kinds of commercially available AgNPs. Results: In this work, AgNPs with higher antibacterial activity compared to the commercially available colloidal silver solutions were prepared and investigated. Bacteria were plated and the antibacterial activity was tested at the same concentration of silver ions in all samples. The AgNPs did not show any significant reduction in the antibacterial activity for an acceptable time period. In addition, AgNPs were transferred to organic phase and retained their antibacterial efficacy in both aqueous and nonaqueous media and exhibited no toxicity in eukaryotic cells. Conclusion: We developed AgNPs with a 20 nm diameter and negative zeta potential with powerful antibacterial activity and low toxicity compared to currently available colloidal silver, suitable for cosmetic preservatives and pharmaceutical preparations administrable to humans and/or animals as needed.

AB - Background: The discovery of new solutions with antibacterial activity as efficient and safe alternatives to common preservatives (such as parabens) and to combat emerging infections and drug-resistant bacterial pathogens is highly expected in cosmetics and pharmaceutics. Colloidal silver nanoparticles (NPs) are attracting interest as novel effective antimicrobial agents for the prevention of several infectious diseases. Methods: Water-soluble, negatively charged silver nanoparticles (AgNPs) were synthesized by reduction with citric and tannic acid and characterized by transmission electron microscopy, dynamic light scattering, zeta potential, differential centrifuge sedimentation, and ultraviolet–visible spectroscopy. AgNPs were tested with model Gram-negative and Gram-positive bacteria in comparison to two different kinds of commercially available AgNPs. Results: In this work, AgNPs with higher antibacterial activity compared to the commercially available colloidal silver solutions were prepared and investigated. Bacteria were plated and the antibacterial activity was tested at the same concentration of silver ions in all samples. The AgNPs did not show any significant reduction in the antibacterial activity for an acceptable time period. In addition, AgNPs were transferred to organic phase and retained their antibacterial efficacy in both aqueous and nonaqueous media and exhibited no toxicity in eukaryotic cells. Conclusion: We developed AgNPs with a 20 nm diameter and negative zeta potential with powerful antibacterial activity and low toxicity compared to currently available colloidal silver, suitable for cosmetic preservatives and pharmaceutical preparations administrable to humans and/or animals as needed.

KW - Antibacterial activity

KW - Long-term effect

KW - Nanoparticle toxicity

KW - Phase transfer

KW - Silver nanoparticles

UR - http://www.scopus.com/inward/record.url?scp=85017186676&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017186676&partnerID=8YFLogxK

U2 - 10.2147/IJN.S127799

DO - 10.2147/IJN.S127799

M3 - Article

AN - SCOPUS:85017186676

VL - 12

SP - 2517

EP - 2530

JO - International Journal of Nanomedicine

JF - International Journal of Nanomedicine

SN - 1176-9114

ER -